Sunesis to Present at Upcoming Investor Conferences
August 31 2017 - 7:00AM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that
the company will present at two upcoming investor conferences.
Daniel Swisher, Chief Executive Officer of
Sunesis, will present at the Wells Fargo Securities 2017 Healthcare
Conference on Thursday, September 7, 2017 at 1:05 PM Eastern Time
at The Westin Boston Waterfront hotel in Boston, MA.
Mr. Swisher will also present at the Cantor
Fitzgerald Global Healthcare Conference on Wednesday, September 27,
2017 at 1:05 PM Eastern Time at the Intercontinental New York
Barclay Hotel in New York City.
Live webcasts of the presentations will be
available on the Sunesis website at http://ir.sunesis.com. A
replay of each webcast will be archived on the "Calendar of Events"
page in the Investors and Media section of the Sunesis website for
two weeks.
About Sunesis
Pharmaceuticals
Sunesis is a biopharmaceutical company focused
on the development and commercialization of new oncology
therapeutics for the future treatment of solid and hematologic
cancers. Sunesis has built an experienced cancer drug development
organization committed to improving the lives of people with
cancer. The company is focused on advancing its novel
kinase-inhibitor pipeline, with an emphasis on establishing proof
of concept that its oral non-covalent BTK-inhibitor, SNS-062,
treats ibrutinib-resistant chronic lymphocytic leukemia. Sunesis is
also supporting investigator-led studies of vosaroxin in acute
myeloid leukemia.
For additional information on Sunesis, please
visit www.sunesis.com.
SUNESIS and the logos are trademarks
of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries:
Maeve Conneighton
Argot Partners
212-600-1902
Dan Swisher
Sunesis Pharmaceuticals Inc.
650-266-3715
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2023 to Sep 2024